autoimmune diseases
ViroCell Biologics and AvenCell Therapeutics partner to accelerate allogeneic CAR-T therapy development
July 29, 2025Contract Manufacturing, Manufacturing Services, Mergers and Acquisitions, Research and Development AvenCell Therapeutics, CAR-T therapy, Contract Development Manufacturing Organisation, Good Manufacturing Practice, Immunology, Oncology, ViroCell Biologics, autoimmune diseases, blood cancer
ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …
GRI Bio announces two global patents granted for Europe and Japan
April 2, 2025Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent
GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …
Twist Bioscience and Ono Pharmaceutical enter agreement for discovery of novel antibodies
August 31, 2023Research and Development Immunology, Ono Pharmaceutical, Twist Bioscience, antibodies, autoimmune diseases
Twist Bioscience has announced that it has entered a drug discovery agreement with Ono Pharmaceutical for the discovery and development …
Kymera Therapeutics reports positive data in cancer drug trials
June 14, 2023Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases
US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …
Scipher Medicine to expand into autoimmune disease therapeutics
April 30, 2021Medical Communications AI, autoimmune diseases
Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …
Interview: GSK’s subcutaneous formulation for Benlysta may help cut down hospital visits
June 22, 2016Research and Development Benlysta, EULAR, Interview, Lupus, NICE, autoimmune diseases, drug trial
UK drugmaker GlaxoSmithKine (LSE: GSK) reported positive results for Benlysta following a late-stage study at the annual European Congress of …
MSD chooses partner to develop ‘game-changing’ cancer therapies
January 6, 2016Research and Development CPABs, Cancer, Cell-Penetrating Alphabodies, Complix, MSD, autoimmune diseases
MSD has entered a research collaboration with biopharma company Complix, using the company’s proprietary technology to develop new treatments for …
Lilly prepares late-stage pipeline boost
July 1, 2011Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology
Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …
GSK signs £64m autoimmune antibody deal
January 7, 2011Research and Development GSK, GlaxoSmithKline, ImmuTune IMP731, Immutep, autoimmune diseases
GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …
